Integrated bioinformatics prediction and dual‐luciferase assay revealed that PHOX2B is a putative target of miR‐125a in NB, while HDAC2 binds to miR‐125a to negatively regulate its expression. The gene discussed is PHOX2B; the disease is neuroblastoma.